http://rdf.ncbi.nlm.nih.gov/pubchem/patent/IE-32525-L

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d202e9e866984fe229f6facc38f1d740
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-65505
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-1403
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-657181
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F9-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F9-6571
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F9-655
filingDate 1968-10-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 1969-04-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber IE-32525-L
titleOfInvention Propenyl phosphonic acid derivatives
abstract 1,239,988. Cis - propenyl phosphonic acid and derivatives thereof. MERCK & CO. Inc. 24 Oct., 1968 [30 Oct., 1967; 15 May, 1968], No. 50636/68. Heading C2C. The invention comprises cis - propenyl phosphonic acid and derivatives thereof of the formula wherein X is an O or S atom, Y is -OR, -SR, halo, or -NR 1 R 2 or other substituted amino group, Z is -OR, SR, halo, or -NR 1 R 2 or other substituted amino group, and each of R, R 1 and R 2 is a hydrogen atom or a substituted or unsubstituted hydrocarbyl or heterocyclic radical, or an acyl radical, and organic or inorganic salts of such compounds in which one or both of Y and Z is an OH group. The invention also includes such compounds but in which NR 1 R 2 is a heterocyclic ring and also such compounds in which Y and Z together from a bridged arylene or substituted or unsubstituted alkylene radical which may contain an interrupting, hetero atom e.g. -S- or -NH- and also compounds in which Y and Z together for an alkylene or arylene bridge and one of Y and Z is nitrogencontaining. When the radical NR 1 R 2 is a heterocyclic radical it may be e.g. morpholinyl, thiomorpholinyl or piperidinyl. The acid, salt and ester products may be obtained by the selective hydrogenation of cis - propynyl phosphonic acid or ester or salt thereof in the presence of a solvent e.g. an inert organic solvent such as a C 1 -C 6 alkanol, ether, benzene, toluene, ethyl acetate or methylene chloride. The hydrogenation is suitably effected in the presence of a hydrogenation catalyst such as Pd, e.g. palladium on calcium carbonate, or a Raney nickel catalyst, and is preferably stopped when one mole of hydrogen has been taken up per mole of the propynyl compound. A small amount of a poisoning agent, e.g. lead acetate for the Pd catalyst, and zinc acetate and/or an organic base for the Raney nickel catalyst, may be added. The dihalides wherein Y and Z are halo are prepared by treating the free phosphonic acid with 2 molecular proportions of a halogenating agent e.g. a thionyl halide, PCl 5 or phosphonyl fluoro bromide in an organic solvent and the compounds where Y and/or Z are -OR or -OR are obtained by treating the dihalide with an appropriate molar amount of a hydroxy compound or mercaptan to yield the diester or monoester halide. The amides (Y and/or Z are NR 1 R 2 ) are prepared by reacting the dihalide with 1 or 2 moles of ammonia or a primary or secondary amine or other amino compound preferably in the presence of a tertiary base to give the phosphonohalidic amides or the diamides. The amide esters or amide thioesters may be obtained by reacting the phosphonohalidic amides with an appropriate hydroxy compound or thiol. Compounds in which X is sulphur may be obtained analogously by using cis-propenyl phosphonothioic dihalide as starting material, the latter being obtainable by reacting cis-propenyl phosphonic dihalide with P 2 S 5 . The products (I) which are halides, phosphonamides or thioates may also be obtained by catalytic hydrogenation of the corresponding propynyl phosphonic halide, phosphonoamide or phosphonothioate, the starting propynyl compounds being obtainable by reacting a metal acetylene Grignard reagent such as a metal acetylene magnesium bromide with the appropriate chlorophosphonic halide, chlorophosphonothioate or chlorophosphonicamide. Di-t-butyl cis-propenyl phosphonate may also be obtained by hydrogenating di-tbutyl-propodienyl phosphonate in the presence of a Pd or carbon catalyst and in the presence of a solvent. The products in which at least one of Y and Z is other than OH may be hydrolysed, e.g. with acid, to produce cis-propenylphosphonic acid or salt thereof. The products (I) may be epoxidized to form the corresponding (Œ)(cis - 1,2 - epoxypropyl)phosphonic acid compounds which may then be resolved, or if Y and/or Z is other than OH they may be hydrolysed prior to epoxidation. Bis - (cis - propenyl)pyrophosphonic acid is obtained by heating cis-propenyl phosphonic acid to 200‹ C. under a nitrogen atmosphere at 200 mm. Hg. pressure. Cic - propenyl phosphonic acid cyclic dianhydride is obtained by adding water to cispropenyl phosphonic dichloride at below 10‹ C. and then heating to 120‹ C. under 50 mm. pressure. Cis - propenylisohypophosphoric acid is obtained in the form of its sodium salt by reacting diethylchlorophosphate with ethyl cis-propenyl phosphonate in ethanol and then adding NaOH. When X in Formula I is a sulphur atom the S atom may be replaced by O by treating the sulphur-containing compound with peroxytrifluoroacetic acid or with bromine water and when Y and/or Z are -SR the products may be converted to phosphonates by treatment with silver nitrate. The (Œ)(cis - 1,2 - epoxypropyl)phosphonic acid salts obtainable from the products (I) have antibacterial properties and may be resolved into the optical enantiomers by forming a salt with an optically active amine, separating the diastereomers and regeneration of the enantiomeric salts.n[GB1239988A]
priorityDate 1967-10-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID702
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393705
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6326969
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451647930
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID297
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419579090
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID18544691
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3084169
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419508771
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID409060395
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID452754495
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456922693
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559215
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10112
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419579030
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419520544
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID19690831
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559581
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14798
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23938
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425193155
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6436667
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414022206
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11192
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3283
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21852392
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID13139
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457815269
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6573
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410510983
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419558592
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID222
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8857
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458396226
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538410
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID402
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5460626
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419550829
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID241
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414022007
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID408271913
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410510980
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457623688
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID421123178
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16685708
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419578251
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559261
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397310
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410541082
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID407330845
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID783
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6326976
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1140
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453467280
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID19779593
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559526
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559219
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24470
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23195050
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458396401
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538408
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414859288
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458392451

Total number of triples: 79.